CSF markers for incipient Alzheimer's disease

This publication has 84 references indexed in Scilit:

• CSF tau protein andβ‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population
  European Journal of Neurology, 2003
• Differentiation of Geriatric Major Depression From Alzheimer’s Disease With CSF Tau Protein Phosphorylated at Threonine 231
  American Journal of Psychiatry, 2003
• CSF markers related to pathogenetic mechanisms in Alzheimer's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
• Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
  Movement Disorders, 2002
• Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group
  Neurobiology of Aging, 2002
• Cerebrospinal Fluid Amyloid β1–42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's Disease
  Experimental Neurology, 2001
• Primary Degenerative Mild Cognitive Impairment: Study Population, Clinical, Brain Imaging and Biochemical Findings
  Dementia and Geriatric Cognitive Disorders, 2001
• Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer’s disease patients
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
• The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological Process
  Dementia and Geriatric Cognitive Disorders, 2001
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984